Loading

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support

PeerCurrent

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Researcher

Zhibing Ming

Nantong University

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews Guidelines

Latest

Everything in the corpus, newest first.

SEP 9, 2026 · JOURNAL ARTICLE

HSP90AA1 Knockdown Enhances Doxorubicin Sensitivity by Promoting Immunogenic Cell Death-Related Signaling and Immune-Related Tumor Microenvironment Remodeling in Breast Cancer

Cancers

Experimental validation in cell lines and a single syngeneic mouse model of a candidate target, lacking human efficacy data, phase 1 trial, or clinical translation to support practice change.

PreliminaryYao Jin Zhibing Ming Chang Xie

Reported

Study populationsBreast cancer cell lines and 4T1 syngeneic…

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support